The Role of PHLPP in Colon Cancer
PHLPP 在结肠癌中的作用
基本信息
- 批准号:9178592
- 负责人:
- 金额:$ 35.74万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2009
- 资助国家:美国
- 起止时间:2009-04-01 至 2019-11-30
- 项目状态:已结题
- 来源:
- 关键词:AdenocarcinomaAdipocytesAffectAutomobile DrivingCancer Cell GrowthCancer CenterCancer EtiologyCell ProliferationCell SurvivalCellsCessation of lifeCitric Acid CycleCollectionColon CarcinomaColorectal CancerDevelopmentDown-RegulationEnsureEventFRAP1 geneGeneticHumanHypoxiaIn VitroIntestinesKnockout MiceKnowledgeMalignant NeoplasmsMediatingMetabolicMetabolic PathwayMetabolic stressMetabolismMolecularNOD/SCID mouseOncogenesPH DomainPathway interactionsPatientsPharmaceutical PreparationsPlayProductionProtein FamilyProtein phosphataseProteinsRas/RafRegulationResearchResistanceRoleSignal TransductionTestingTissuesTranslationsTreatment EfficacyTumor Suppressor ProteinsUnited StatesXenograft Modelcancer cellcancer initiationcancer therapychemotherapycolon cancer patientscolon tumorigenesisdesignexperimental studyglucose uptakeimprovedin vivoinsightleucine-rich repeat proteinlipid biosynthesislipid metabolismmTOR Inhibitormacromoleculemetabolomicsmouse modelnoveloutcome forecastpublic health relevancestable isotopesuccesstherapy resistanttreatment strategytumor metabolismtumor progressiontumorigenesis
项目摘要
DESCRIPTION (provided by applicant): Colorectal cancer (CRC) is the second leading cause of cancer-related deaths in the United States. Approximately 142,000 new cases and 51,000 deaths are predicted for the year 2013. A better understanding of the molecular events leading to cancer progression and chemoresistance is needed in order to improve the overall survival of CRC patients. Our lab has been intensively focused on elucidating the role of a novel family of protein phosphatases, PHLPP (PH domain Leucine-rich-repeats Protein Phosphatase), in inhibiting CRC initiation and progression. We have made substantial progress in understanding the functional importance of PHLPP as a tumor suppressor as well as the molecular mechanism underlying PHLPP regulation. In this proposed study, we will determine the effect of PHLPP-loss on modulating lipid metabolism in CRC. Although recent advances in cancer metabolism research have begun to elucidate how metabolic changes support cancer cell growth and survival, the regulation and functional importance of altered lipid metabolism in CRC remain elusive. This proposal centers on a novel hypothesis that PHLPP-loss plays a pivotal role in driving CRC progression by promoting lipogenesis. In exciting recent findings, we demonstrate that downregulation of PHLPP expression results in an increase in the expression of activated SREBP1, a key activator of lipid biosynthesis. Consistently, MEF cells isolated from PHLPP knockout mice have enhanced lipogenesis during differentiation into adipocytes. In addition, we have found that silencing PHLPP expression leads to increased glucose uptake, lactate production, Krebs cycle activity, and triacylglycerides accumulation in CRC cells, suggesting a role of PHLPP in regulating cellular metabolism. The central hypothesis driving this proposed study is that PHLPP plays an essential role in inhibiting lipogenesis by negatively regulating the PI3K/Akt/mTOR pathway, and loss of PHLPP expression promotes CRC progression as the result of metabolic reprogramming. The following specific aims are proposed: 1) to delineate the molecular mechanism by which PHLPP regulates lipogenesis in CRC cells. We will perform the Stable Isotope-Resolved Metabolomics (SIRM) analysis to determine how PHLPP-loss affects lipid metabolism in CRC cells; 2) to determine the functional importance of PHLPP-mediated regulation of lipogenesis. We will test if PHLPP-loss renders CRC cells more resistant to metabolic stress and chemotherapy drugs as the result of alterations in lipogenesis; and 3) to define the role of PHLPP in suppressing lipogenesis in vivo. The effect of PHLPP-loss on modulating lipid metabolism will be determined using both genetically modified mouse models and patient-derived xenograft models. Results from our studies will fill an important knowledge gap on how altered lipogenesis affects the prognosis and treatment efficacy in CRC patients. Ultimately, by providing insight into the mechanisms by which PHLPP-mediated lipogenesis, our findings will help to develop new treatment strategies in CRC patients.
描述(由申请人提供): 结直肠癌(CRC)是美国癌症相关死亡的第二大原因。预计2013年约有142 000例新病例和51 000例死亡。为了提高CRC患者的总体生存率,需要更好地了解导致癌症进展和化疗耐药性的分子事件。我们的实验室一直致力于阐明一个新的蛋白磷酸酶家族PHLPP(PH结构域富含亮氨酸重复序列的蛋白磷酸酶)在抑制CRC发生和发展中的作用。我们在了解PHLPP作为肿瘤抑制因子的功能重要性以及PHLPP调控的分子机制方面取得了实质性进展。在这项拟议的研究中,我们将确定PHLPP损失对调节CRC脂质代谢的影响。尽管癌症代谢研究的最新进展已经开始阐明代谢变化如何支持癌细胞生长和存活,但CRC中脂质代谢改变的调节和功能重要性仍然难以捉摸。这一提议基于一个新的假设,即PHLPP-丢失通过促进脂肪生成在驱动CRC进展中起关键作用。在令人兴奋的最新研究结果中,我们证明了PHLPP表达的下调导致激活的SREBP 1表达的增加,SREBP 1是脂质生物合成的关键激活剂。一致地,从PHLPP敲除小鼠分离的MEF细胞在分化成脂肪细胞期间具有增强的脂肪生成。此外,我们发现沉默PHLPP表达导致CRC细胞中葡萄糖摄取、乳酸盐产生、克雷布斯循环活性和三酰甘油酯积累增加,表明PHLPP在调节细胞代谢中的作用。推动这项拟议研究的中心假设是,PHLPP通过负调节PI 3 K/Akt/mTOR通路在抑制脂肪生成中起重要作用,并且PHLPP表达的丧失作为代谢重编程的结果促进CRC进展。提出以下具体目标:1)阐明PHLPP调节CRC细胞中脂肪生成的分子机制。我们将进行稳定同位素解析代谢组学(SIRM)分析,以确定PHLPP损失如何影响CRC细胞中的脂质代谢; 2)确定PHLPP介导的脂肪生成调节的功能重要性。我们将测试PHLPP-损失是否使CRC细胞对代谢应激和化疗药物更具抗性,这是脂肪生成改变的结果;和3)确定PHLPP在体内抑制脂肪生成中的作用。将使用遗传修饰的小鼠模型和患者来源的异种移植物模型来确定PHLPP损失对调节脂质代谢的影响。我们的研究结果将填补一个重要的知识空白,改变脂肪生成如何影响结直肠癌患者的预后和治疗效果。最终,通过深入了解PHLPP介导的脂肪生成机制,我们的研究结果将有助于开发CRC患者的新治疗策略。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Tianyan Gao其他文献
Tianyan Gao的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Tianyan Gao', 18)}}的其他基金
Study of PTPRF-Mediated Regulation of Wnt Signaling
PTPRF 介导的 Wnt 信号转导调节研究
- 批准号:
10677248 - 财政年份:2023
- 资助金额:
$ 35.74万 - 项目类别:
Lafora Epilepsy – Basic mechanisms to therapy
拉福拉癫痫 — 治疗的基本机制
- 批准号:
10436430 - 财政年份:2016
- 资助金额:
$ 35.74万 - 项目类别:
Diversity Supplement Carolina Galeano-Naranjo
多样性补充卡罗莱纳·加莱亚诺-纳兰霍
- 批准号:
10811185 - 财政年份:2009
- 资助金额:
$ 35.74万 - 项目类别:
相似国自然基金
支链氨基酸代谢紊乱调控“Adipocytes - Macrophages Crosstalk”诱发2型糖尿病脂肪组织功能和结构障碍的作用及机制
- 批准号:81970721
- 批准年份:2019
- 资助金额:55.0 万元
- 项目类别:面上项目
相似海外基金
New development of cellular regeneration therapy in jaw bone using stem cells derived from adipocytes jaw bone
利用颌骨脂肪细胞来源的干细胞进行颌骨细胞再生治疗的新进展
- 批准号:
23K16058 - 财政年份:2023
- 资助金额:
$ 35.74万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
A novel mechanism of insulin resistance mediated by uric acid metabolism in adipocytes
脂肪细胞尿酸代谢介导胰岛素抵抗的新机制
- 批准号:
23K10969 - 财政年份:2023
- 资助金额:
$ 35.74万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Hypertrophic adipocytes as biophysical mediators of breast cancer progression
肥大脂肪细胞作为乳腺癌进展的生物物理介质
- 批准号:
10751284 - 财政年份:2023
- 资助金额:
$ 35.74万 - 项目类别:
Development of adipocytes for gene therapy that avoids cellular stress due to overexpression of therapeutic proteins
开发用于基因治疗的脂肪细胞,避免因治疗蛋白过度表达而造成的细胞应激
- 批准号:
23H03065 - 财政年份:2023
- 资助金额:
$ 35.74万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Functional analysis of bitter taste receptors in adipocytes and hepatocytes
脂肪细胞和肝细胞中苦味受体的功能分析
- 批准号:
23K05107 - 财政年份:2023
- 资助金额:
$ 35.74万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Elucidation of mechanisms for conversion of adipocytes to cancer-associated fibroblasts in osteosarcoma microenvironment
阐明骨肉瘤微环境中脂肪细胞转化为癌症相关成纤维细胞的机制
- 批准号:
23K19518 - 财政年份:2023
- 资助金额:
$ 35.74万 - 项目类别:
Grant-in-Aid for Research Activity Start-up
Study on UCP-1 independent metabolic regulation by brown adipocytes
棕色脂肪细胞对UCP-1独立代谢调节的研究
- 批准号:
23K18303 - 财政年份:2023
- 资助金额:
$ 35.74万 - 项目类别:
Grant-in-Aid for Challenging Research (Exploratory)
NKA/CD36 signaling in adipocytes promotes oxidative stress and drives chronic inflammation in atherosclerosis
脂肪细胞中的 NKA/CD36 信号传导促进氧化应激并驱动动脉粥样硬化的慢性炎症
- 批准号:
10655793 - 财政年份:2023
- 资助金额:
$ 35.74万 - 项目类别:
The mechanisms of the signal transduction from brown adipocytes to afferent neurons and its significance.
棕色脂肪细胞向传入神经元的信号转导机制及其意义。
- 批准号:
23K05594 - 财政年份:2023
- 资助金额:
$ 35.74万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Characterizing breast cancer invasion and proliferation when co-aggregated with adipocytes in multicellular spheroids created with a custom bioreactor to augment cell-cell connectivity.
当与多细胞球体中的脂肪细胞共聚集时,表征乳腺癌的侵袭和增殖,该多细胞球体是用定制生物反应器创建的,以增强细胞间的连接。
- 批准号:
10334113 - 财政年份:2022
- 资助金额:
$ 35.74万 - 项目类别: